Scarless Thyroid Surgery
The transoral approach to thyroid and parathyroid removal is currently the only surgical option that does not leave a visible cutaneous scar. Additionally, this approach allows access to the bilateral central neck compartments, requires minimal additional instrumentation, and has a complication rate comparable to the traditional open approach. As this is being adapted in North America, endocrinologists, general surgeons and otolaryngologists need to be aware of the procedures risks and benefits.
This activity is designed to meet the educational needs of Endocrinologists, General Surgeons, and Otolaryngologists.
At the conclusion of this activity, participants should be able to:
- State the advantages and disadvantages of the transoral thyroidectomy and parathyroidectomy approach
- Identify the best candidate for the approach
- Explain the history of remote access or scarless thyroid and parathyroid surgery
METHOD OF PARTICIPATION
This activity is in an online video module format and includes one didactic presentation.
To receive a certificate you should:
- View the presentation in this enduring material
- Complete and submit the CME/CE evaluation form
The estimated time to complete this activity, including review of the materials, is 1.00 hour(s).
Hardware/software requirements: Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox, and Google Chrome.
If you have questions about the participation process, please e-mail the Division of Continuing Professional Development, firstname.lastname@example.org or phone 713.798.8237.
TERM OF APPROVAL
April 2021 through March 2023. Original release date: April 2021
This CME/CE activity is designed for use by healthcare professionals for educational purposes only. Information and opinion offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.
Baylor College of Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Links are provided to other Internet sites solely for the convenience of users. Once you link to another site, you are subject to the site's terms and conditions of use including copyright and licensing restrictions.
The Division of Continuing Professional Development (DCPD) makes every effort to develop CME/CE activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support SM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.
Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.
If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME/CE activity evaluation candidly.
Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with the applicable law.
Baylor College of Medicine requires that all contributors disclose an unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products, and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.
All of the relevant financial relationships listed for these individuals have been mitigated.
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Michael Fordis, MD - Reviewer
Senior Associate Dean and Director
Division of Continuing Professional Development
Baylor College of Medicine
Nothing to disclose
Raymon H. Grogan, MD MS FACS - Program Director, Contributor
Associate Professor of Surgery
Section Chief of Endocrine Surgery
Baylor St. Luke’s Medical Center
Division of General Surgery
Consultancy: Johnson & Johnson, Medtronic
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation